NCT04062656 2024-03-12
IMAGINE
University Hospital, Essen
Phase 2 Unknown
Clinical Trials
79 trialsNCT06194981 2024-01-12
Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage
The First Affiliated Hospital of Zhengzhou University
Unknown
NCT06196554 2024-01-09
Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Unknown
NCT06197438 2024-01-09
Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT05859477 2024-01-02
NIVOFGFR2
Kidney Cancer Research Bureau
Phase 2 Unknown
NCT04999332 2023-11-15
LOTS
National Cheng-Kung University Hospital
Phase 2 Unknown
NCT02338518 2023-09-29
SVOSA
Jinling Hospital, China
Phase 3 Unknown
NCT05982301 2023-08-08
Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric Cancer
Fudan University
Phase 2 Unknown
NCT04250948 2023-08-01
Efficacy of Perioperative Chemotherapy Plus PD-1 Antibody in the Locally Advanced Gastric Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT05948449 2023-07-17
To Evaluate the Efficacy and Safety of Cadonilimab With SOX as Neoadjuvant Therapy for Resectable Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
Sichuan University
Phase 2 Unknown
NCT05844371 2023-05-06
Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery
Yixing People's Hospital
Phase 2 Unknown
NCT04819971 2023-04-25
Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC
The First Affiliated Hospital of Zhengzhou University
Phase 2 Unknown
NCT05052931 2023-04-13
Nab-paclitaxel Combined With Oxaliplatin and S-1 for Perioperative Treatment of Advanced Gastric Cancer
Xijing Hospital
Phase 2 Unknown
NCT05800080 2023-04-05
An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC
Xijing Hospital
Phase NA Unknown
NCT05325528 2023-02-01
Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases
Zhejiang University
Phase 2/3 Unknown
NCT05608785 2022-11-08
Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes
Henan Cancer Hospital
Phase 1/2 Unknown
NCT05594381 2022-10-26
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT05396326 2022-05-31
A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Phase 1 Unknown
NCT05346874 2022-05-26
Neoadjuvant TACiE in Locally Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT05385900 2022-05-23
ICTCPTLAGC
Xijing Hospital
Phase NA Unknown
NCT03001726 2022-05-06
To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.
Shanghai Zhongshan Hospital
Unknown
NCT05216237 2022-04-11
A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer
Affiliated Hospital of Qinghai University
Phase 2 Unknown
NCT04119622 2022-03-11
Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer
ChineseAMS
Phase 2 Unknown
NCT03801668 2022-01-04
Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
Huazhong University of Science and Technology
Phase 3 Unknown
NCT05111444 2021-11-08
Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Fudan University
Phase 2 Unknown
NCT02934464 2021-09-13
ARMANI
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 3 Unknown
NCT04982939 2021-08-31
Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT05002686 2021-08-24
Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis
Ruijin Hospital
Phase 2/3 Unknown
NCT04358354 2021-07-19
Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Unknown
NCT04943653 2021-07-06
IPXELOX
Seoul St. Mary's Hospital
Phase 1/2 Unknown
NCT04913896 2021-06-04
CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy
The First Hospital of Jilin University
Unknown
NCT03961867 2021-06-01
Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Unknown
NCT04393584 2021-04-13
RusGCG-01
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
NCT04442984 2021-04-13
IRIGA
Blokhin's Russian Cancer Research Center
Phase 2 Unknown
NCT04354662 2021-02-18
Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT01359397 2021-01-27
B-DOCT
The Netherlands Cancer Institute
Phase 2 Unknown
NCT04351867 2020-07-16
A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer
Henan Cancer Hospital
Phase 3 Unknown
NCT04367025 2020-04-29
Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer
Chinese PLA General Hospital
Phase 2 Unknown
NCT01761461 2020-03-25
ARTIST-II
Samsung Medical Center
Phase 3 Unknown
NCT04135781 2020-03-23
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage â…¢ Gastric Cancer
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT04263870 2020-02-11
CTSCAPOXSEA
Sichuan University
Phase 2 Unknown
NCT04065282 2020-02-10
The Purpose of This Study is to Evaluate the Efficacy and Safety of Sintilimab in Combination With Xelox as Neoadjuvant Therapy for Patients With Resectable Locally Advanced Gastric or Gastroesophageal Adenocarcinoma.
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT02845986 2020-02-05
CLASS-04
Fujian Medical University
Phase 2 Unknown
NCT04202484 2019-12-17
Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma
RenJi Hospital
Phase 2 Unknown
NCT03263741 2019-07-08
Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric Cancer
Affiliated Hospital of Qinghai University
Phase 2 Unknown
NCT03990103 2019-06-19
S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites
China Medical University, China
Phase 2 Unknown
NCT00183898 2019-05-16
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
University of Southern California
Phase 2 Unknown
NCT03817411 2019-05-07
Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer
Taizhou EOC Pharma Co., Ltd.
Phase 2 Unknown
NCT02177552 2019-02-15
SEED
Rigshospitalet, Denmark
Phase 2 Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown